HB 236 extends the required blood testing window for combat sports athletes in Maryland from 30 days to 90 days. It affects boxers, kickboxers, wrestlers, and mixed martial arts competitors seeking licenses or participating in contests. The bill mandates that applicants and licensed contestants must provide documented evidence of negative tests for HIV, hepatitis B, and hepatitis C within 90 days prior to license application or competition. This change modifies existing Maryland law (Sections 4-101 and 4-304.1 of the Business Regulation Article) to align testing timing with the State Athletic Commission's requirements. The bill takes effect October 1, 2026.
SB 88 creates a limited license for music therapists in Maryland who are completing full licensure requirements. It allows the State Board of Examiners to issue these licenses to applicants who meet education standards (including American Music Therapy Association certification), pay fees, and practice under supervision of a fully licensed music therapist. The limited license is valid for one year, renewable once, but expires if full licensure isn't obtained within two years. This does not replace existing services by audiologists or speech-language pathologists, and the practice of music therapy is defined as using music-based interventions within a therapeutic relationship. The bill directly affects aspiring music therapists seeking licensure and the State Board of Examiners.
HB 7 authorizes Maryland's State Board of Examiners to issue limited licenses for music therapists who are completing full licensing requirements but lack sufficient clinical experience. This directly affects new music therapists and healthcare facilities needing to hire them under supervision while they fulfill certification steps. The bill creates a 1-year limited license (renewable once) requiring direct supervision by a fully licensed music therapist, with a 2-year deadline to obtain full licensure. It explicitly states limited licenses cannot replace services from audiologists or speech-language pathologists. The policy change streamlines entry into the profession without altering existing practice standards for music therapy.
SB 385 (The Vax Act) requires Maryland’s Secretary of Health to issue evidence-based recommendations for immunizations, screenings, and preventive services, aligning with guidance from major medical organizations like the CDC and U.S. Preventive Services Task Force. It expands pharmacists’ authority to administer vaccines (including those recommended by CDC or the Secretary) to patients aged 3+ after completing specific training and certification, while mandating health insurers to cover these services without cost-sharing. The bill also repeals outdated pertussis-related provisions and updates reporting requirements for pharmacists. This directly affects pharmacists, health insurers, and patients seeking preventive care, aiming to improve access to vaccinations and screenings.
SB 333 creates the Interstate Podiatric Medical Licensure Compact, allowing podiatrists (foot and ankle specialists) licensed in Maryland to practice in other participating states more easily. The bill establishes a streamlined process for obtaining an "expedited license" in multiple states without altering existing state licensing laws, requiring podiatrists to pass national exams and pass background checks. Crucially, it mandates that podiatrists follow the rules of the state where the patient is located during treatment, not where the provider is licensed. This compact directly affects licensed podiatrists seeking multi-state practice and state licensing boards overseeing medical practice.
HB 637 ("The Vax Act") requires Maryland's Secretary of Health to issue science-based recommendations for immunizations, screenings, and preventive services using guidance from major medical organizations like the CDC and American Academy of Pediatrics. It expands pharmacists' authority to administer flu, COVID-19, and emergency vaccines to patients aged 3 and older (previously limited to 18+ for some vaccines) after completing specific training. The bill also mandates that health insurance plans cover these recommended services without cost-sharing for patients. This directly affects pharmacists, health insurers, and Maryland residents seeking preventive care, particularly children and adults needing routine vaccinations.
SB 444 repeals an exemption that previously allowed intermediate care facilities offering substance use disorder treatment to change bed capacity without a certificate of need. It creates a new exemption for facilities providing *medically managed residential substance use disorder treatment services*, removing the requirement for a certificate of need if they submit 45 days' written notice to the Commission and the Commission determines the change aligns with the state health plan, improves service efficiency, and serves the public interest. This bill directly affects intermediate care facilities focused on substance use disorder treatment by reducing regulatory barriers for expanding bed capacity or establishing new facilities. The key mechanism is replacing a certificate of need with a streamlined notice-and-review process administered by the Commission. (SB 444, "Certificate of Need - Intermediate Health Care Facilities," 2026)
SB 790, the Public Health Reform Act, requires the Maryland Department of Health to organize the Maryland Medical Reserve Corps - a statewide volunteer network for emergencies like disease outbreaks or disasters. It allows county health directors to hire staff without state approval if positions are fully funded locally and to enter contracts if the state fails to respond within a set timeframe. The bill creates the Public Health Workforce Development Fund (using interest earnings and transfers from another fund) to support workforce training, and mandates health equity impact assessments for new legislation. These changes directly affect county health departments, state health agencies, and public health emergency response systems.
This bill requires health insurers and health plans in Maryland to cover salpingectomy (surgery to remove fallopian tubes) specifically for ovarian cancer prevention as a standard benefit, with no out-of-pocket costs like copays or deductibles for patients. It applies to all health insurance policies issued in Maryland after January 1, 2027, directly affecting women who might choose this preventive surgery and the insurers providing coverage. The key provision bans cost-sharing for this procedure, except when an individual is enrolled in a high-deductible health plan meeting federal criteria. This ensures access to a proven preventive measure without financial barriers for most patients.
SB 504 prohibits businesses from selling consumer personal data to buyers who intend to use it for immigration enforcement. It defines "sensitive data" to include immigration status, racial origin, health information, and sexual orientation, requiring businesses to handle such data more carefully. The bill also mandates public record custodians to prevent unauthorized disclosure - especially for immigration enforcement - and requires message switching systems to implement access controls. These changes aim to strengthen privacy protections for Maryland residents while modifying existing data privacy laws in the state code.